Journey Net Receivables vs Short Term Investments Analysis

DERM Stock

USD 3.90 0.10 2.63%

Journey Medical financial indicator trend analysis is infinitely more than just investigating Journey Medical Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Journey Medical Corp is a good investment. Please check the relationship between Journey Medical Net Receivables and its Short Term Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Net Receivables vs Short Term Investments

Net Receivables vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Journey Medical Corp Net Receivables account and Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Journey Medical's Net Receivables and Short Term Investments is 0.42. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Journey Medical Corp, assuming nothing else is changed. The correlation between historical values of Journey Medical's Net Receivables and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Journey Medical Corp are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Net Receivables i.e., Journey Medical's Net Receivables and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.42

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Net Receivables

Short Term Investments

Short Term Investments is an item under the current assets section of Journey Medical balance sheet. It contains any investments Journey Medical Corp undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Journey Medical Corp can easily liquidate in the marketplace.

Most indicators from Journey Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Journey Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Journey Medical's Selling General Administrative is very stable compared to the past year. As of the 1st of June 2024, Sales General And Administrative To Revenue is likely to grow to 3.97, while Tax Provision is likely to drop about 102.6 K.

	2021	2022	2023	2024 (projected)
Interest Expense	7.0M	2.0M	1.7M	1.6M
Depreciation And Amortization	2K	60K	3.9M	4.0M

Interest Expense Depreciation And Amortization

Journey Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.78	0.62	0.49	0.48	0.92	-0.18	0.2	-0.83	0.05	0.9	-0.11	0.55	0.99	-0.59	0.31	0.66	0.12	0.8	0.59	0.88	0.78	0.98	0.47	-0.62	0.87
Short Long Term Debt Total	0.78		0.53	0.41	0.29	0.89	-0.05	0.34	-0.82	0.14	0.63	-0.51	0.58	0.84	-0.14	0.19	0.89	0.37	0.69	0.79	0.95	0.68	0.85	0.35	-0.48	0.72
Other Current Liab	0.62	0.53		0.9	-0.16	0.67	-0.24	0.3	-0.6	0.38	0.75	-0.62	-0.07	0.69	-0.17	-0.14	0.74	0.71	0.72	0.47	0.65	0.83	0.72	0.74	0.06	0.2
Total Current Liabilities	0.49	0.41	0.9		-0.23	0.53	-0.24	0.21	-0.46	0.67	0.64	-0.64	-0.2	0.55	0.07	-0.15	0.67	0.75	0.58	0.45	0.54	0.72	0.6	0.79	0.3	0.02
Total Stockholder Equity	0.48	0.29	-0.16	-0.23		0.28	-0.36	-0.6	-0.03	-0.33	0.31	0.49	0.22	0.4	-0.33	0.35	-0.1	-0.54	-0.12	0.12	0.19	-0.17	0.36	0.16	-0.67	0.66
Property Plant And Equipment Net	0.92	0.89	0.67	0.53	0.28		-0.07	0.43	-0.9	0.13	0.74	-0.35	0.53	0.93	-0.36	0.24	0.85	0.39	0.84	0.82	0.96	0.83	0.95	0.46	-0.49	0.76
Current Deferred Revenue	-0.18	-0.05	-0.24	-0.24	-0.36	-0.07		0.34	-0.05	-0.28	-0.16	-0.17	0.23	-0.13	0.11	0.53	0.02	0.05	0.11	-0.18	-0.05	0.01	-0.13	-0.71	-0.24	-0.09
Net Debt	0.2	0.34	0.3	0.21	-0.6	0.43	0.34		-0.68	0.21	0.08	-0.36	0.54	0.23	-0.17	-0.06	0.54	0.44	0.69	0.48	0.5	0.64	0.27	-0.12	0.04	0.15
Retained Earnings	-0.83	-0.82	-0.6	-0.46	-0.03	-0.9	-0.05	-0.68		-0.18	-0.71	0.34	-0.74	-0.85	0.49	-0.15	-0.82	-0.32	-0.95	-0.7	-0.94	-0.91	-0.87	-0.26	0.44	-0.73
Accounts Payable	0.05	0.14	0.38	0.67	-0.33	0.13	-0.28	0.21	-0.18		0.09	-0.39	-0.14	0.06	0.4	-0.19	0.35	0.52	0.17	0.39	0.22	0.3	0.13	0.59	0.6	-0.22
Cash	0.9	0.63	0.75	0.64	0.31	0.74	-0.16	0.08	-0.71	0.09		-0.23	0.32	0.92	-0.57	0.21	0.58	0.17	0.77	0.31	0.73	0.79	0.91	0.51	-0.45	0.66
Non Current Assets Total	-0.11	-0.51	-0.62	-0.64	0.49	-0.35	-0.17	-0.36	0.34	-0.39	-0.23		0.15	-0.26	-0.46	0.22	-0.77	-0.88	-0.38	-0.45	-0.46	-0.48	-0.31	-0.33	-0.28	0.2
Non Currrent Assets Other	0.55	0.58	-0.07	-0.2	0.22	0.53	0.23	0.54	-0.74	-0.14	0.32	0.15		0.52	-0.54	0.35	0.35	-0.28	0.59	0.38	0.62	0.45	0.49	-0.31	-0.66	0.79
Cash And Short Term Investments	0.99	0.84	0.69	0.55	0.4	0.93	-0.13	0.23	-0.85	0.06	0.92	-0.26	0.52		-0.52	0.27	0.74	0.22	0.83	0.6	0.91	0.82	1.0	0.48	-0.59	0.83
Net Receivables	-0.59	-0.14	-0.17	0.07	-0.33	-0.36	0.11	-0.17	0.49	0.4	-0.57	-0.46	-0.54	-0.52		-0.12	0.01	0.42	-0.52	0.04	-0.32	-0.43	-0.47	0.03	0.62	-0.67
Good Will	0.31	0.19	-0.14	-0.15	0.35	0.24	0.53	-0.06	-0.15	-0.19	0.21	0.22	0.35	0.27	-0.12		0.0	-0.23	0.14	-0.02	0.16	0.03	0.25	-0.26	-0.55	0.42
Common Stock Shares Outstanding	0.66	0.89	0.74	0.67	-0.1	0.85	0.02	0.54	-0.82	0.35	0.58	-0.77	0.35	0.74	0.01	0.0		0.72	0.77	0.83	0.91	0.81	0.78	0.47	-0.16	0.42
Short Term Investments	0.12	0.37	0.71	0.75	-0.54	0.39	0.05	0.44	-0.32	0.52	0.17	-0.88	-0.28	0.22	0.42	-0.23	0.72		0.4	0.56	0.41	0.51	0.29	0.52	0.43	-0.27
Non Current Liabilities Total	0.8	0.69	0.72	0.58	-0.12	0.84	0.11	0.69	-0.95	0.17	0.77	-0.38	0.59	0.83	-0.52	0.14	0.77	0.4		0.56	0.87	0.98	0.84	0.29	-0.34	0.61
Other Current Assets	0.59	0.79	0.47	0.45	0.12	0.82	-0.18	0.48	-0.7	0.39	0.31	-0.45	0.38	0.6	0.04	-0.02	0.83	0.56	0.56		0.82	0.58	0.65	0.49	-0.16	0.47
Other Stockholder Equity	0.88	0.95	0.65	0.54	0.19	0.96	-0.05	0.5	-0.94	0.22	0.73	-0.46	0.62	0.91	-0.32	0.16	0.91	0.41	0.87	0.82		0.85	0.93	0.41	-0.46	0.74
Total Liab	0.78	0.68	0.83	0.72	-0.17	0.83	0.01	0.64	-0.91	0.3	0.79	-0.48	0.45	0.82	-0.43	0.03	0.81	0.51	0.98	0.58	0.85		0.84	0.43	-0.2	0.51
Total Current Assets	0.98	0.85	0.72	0.6	0.36	0.95	-0.13	0.27	-0.87	0.13	0.91	-0.31	0.49	1.0	-0.47	0.25	0.78	0.29	0.84	0.65	0.93	0.84		0.51	-0.53	0.8
Short Term Debt	0.47	0.35	0.74	0.79	0.16	0.46	-0.71	-0.12	-0.26	0.59	0.51	-0.33	-0.31	0.48	0.03	-0.26	0.47	0.52	0.29	0.49	0.41	0.43	0.51		0.26	0.11
Intangible Assets	-0.62	-0.48	0.06	0.3	-0.67	-0.49	-0.24	0.04	0.44	0.6	-0.45	-0.28	-0.66	-0.59	0.62	-0.55	-0.16	0.43	-0.34	-0.16	-0.46	-0.2	-0.53	0.26		-0.84
Common Stock	0.87	0.72	0.2	0.02	0.66	0.76	-0.09	0.15	-0.73	-0.22	0.66	0.2	0.79	0.83	-0.67	0.42	0.42	-0.27	0.61	0.47	0.74	0.51	0.8	0.11	-0.84

Click cells to compare fundamentals

Journey Medical Account Relationship Matchups

Journey Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.9M	51.9M	97.3M	105.2M	76.8M	73.0M
Short Long Term Debt Total	5.3M	5.4M	910K	23.0M	17.7M	16.8M
Other Current Liab	18.8M	4.5M	4.5M	22.2M	20.4M	20.8M
Total Current Liabilities	20.9M	28.1M	51.6M	66.8M	41.9M	46.9M
Total Stockholder Equity	2.8M	10.3M	42.0M	17.0M	20.4M	19.3M
Property Plant And Equipment Net	1.2M	89K	175K	189K	101K	96.0K
Net Debt	502K	(2.8M)	(48.2M)	(9.0M)	(9.7M)	(10.2M)
Retained Earnings	(163K)	5.1M	(38.9M)	(68.5M)	(72.4M)	(76.0M)
Accounts Payable	2.0M	1.8M	22.8M	36.6M	18.3M	15.5M
Cash	4.8M	8.2M	49.1M	32.0M	27.4M	26.1M
Non Current Assets Total	8.6M	16.7M	12.8M	27.5M	20.4M	16.4M
Non Currrent Assets Other	656K	3.0M	6K	150K	95K	5.7K
Cash And Short Term Investments	4.8M	8.2M	49.1M	32.0M	27.4M	26.1M
Net Receivables	19.0M	23.9M	23.1M	28.2M	15.2M	17.6M
Liabilities And Stockholders Equity	33.9M	51.9M	97.3M	105.2M	76.8M	73.0M
Non Current Liabilities Total	10.2M	13.6M	3.6M	21.3M	14.6M	13.9M
Other Current Assets	655K	1.7M	2.4M	3.3M	3.6M	3.2M
Other Stockholder Equity	2.9M	5.2M	80.9M	85.5M	92.7M	88.1M
Total Liab	31.1M	41.6M	55.2M	88.2M	56.5M	93.1M
Total Current Assets	25.3M	35.2M	84.5M	77.7M	56.5M	53.6M
Intangible Assets	7.4M	15.0M	12.6M	27.2M	20.3M	21.3M
Inventory	857K	1.4M	9.9M	14.2M	10.2M	8.2M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Journey Medical Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:

How To Invest In Journey

Details

Is Journey Stock a good investment?

Details

What is Journey Medical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Journey Stock analysis

When running Journey Medical's price analysis, check to measure Journey Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Journey Medical is operating at the current time. Most of Journey Medical's value examination focuses on studying past and present price action to predict the probability of Journey Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Journey Medical's price. Additionally, you may evaluate how the addition of Journey Medical to your portfolios can decrease your overall portfolio volatility.

	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Commodity Directory Find actively traded commodities issued by global exchanges
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets

Is Journey Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.17)

Revenue Per Share

4.273

Quarterly Revenue Growth

0.067

Return On Assets

0.0042

Return On Equity

(0.41)

The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Journey Net Receivables vs Short Term Investments Analysis

Net Receivables vs Short Term Investments

Net Receivables vs Short Term Investments Correlation Analysis

Correlation Coefficient

Net Receivables

Short Term Investments

Journey Medical fundamental ratios Correlations

Journey Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Journey Medical fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Journey Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.98	Total Assets
Total Liab	+ 0.98	Non Current Liabilities Total
Other Stockholder Equity	+ 0.96	Property Plant And Equipment Net
Other Stockholder Equity	+ 0.95	Short Long Term Debt Total

Non Current Liabilities Total	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Total Liab	- 0.91	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Short Term Investments	- 0.88	Non Current Assets Total
Total Current Assets	- 0.87	Retained Earnings